<bill session="116" type="s" number="1391" updated="2022-02-08T23:21:46Z">
  <state datetime="2019-05-09">REFERRED</state>
  <status>
    <introduced datetime="2019-05-09"/>
  </status>
  <introduced datetime="2019-05-09"/>
  <titles>
    <title type="display">Fair Accountability and Innovative Research Drug Pricing Act of 2019</title>
    <title type="short" as="introduced">Fair Accountability and Innovative Research Drug Pricing Act of 2019</title>
    <title type="official" as="introduced">A bill to require reporting regarding certain drug price increases, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="B001230"/>
  <cosponsors>
    <cosponsor bioguide_id="B001310" joined="2019-05-09"/>
    <cosponsor bioguide_id="B000944" joined="2019-09-19"/>
    <cosponsor bioguide_id="C001096" joined="2019-09-09"/>
    <cosponsor bioguide_id="H001061" joined="2019-08-01"/>
    <cosponsor bioguide_id="K000383" joined="2019-08-01"/>
    <cosponsor bioguide_id="M001153" joined="2019-05-09"/>
    <cosponsor bioguide_id="S001203" joined="2019-05-09"/>
  </cosponsors>
  <actions>
    <action datetime="2019-05-09">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-05-09" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="2296" relation="unknown"/>
    <bill session="116" type="s" number="1895" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Business records"/>
    <term name="Civil actions and liability"/>
    <term name="Congressional oversight"/>
    <term name="Consumer affairs"/>
    <term name="Corporate finance and management"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Inflation and prices"/>
    <term name="Manufacturing"/>
    <term name="Marketing and advertising"/>
    <term name="Medical research"/>
    <term name="Prescription drugs"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary date="2021-01-13T17:42:40Z" status="Introduced in Senate">Fair Accountability and Innovative Research Drug Pricing Act of 2019

This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month. Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug.</summary>
</bill>
